Copeptin: Up-to-date diagnostic and prognostic role highlight

被引:11
作者
Abdelmageed, Marwa [1 ,4 ]
Guzelgul, Figen [2 ,3 ]
机构
[1] Tokat Gaziosmanpasa Univ, Fac Med, Dept Med Biochem, Tokat City, Turkiye
[2] Tokat Gaziosmanpasa Univ, Fac Pharm, Dept Biochem, Tokat City, Turkiye
[3] Kaleardi Mahallesi Muhittin Fisunoglu St,Ali Sevk, TR-60100 Tokat, Turkiye
[4] Bahcesehir 2,Kisim Mahallesi Sehit Astegmen Furka, TR-34488 Istanbul, Turkiye
关键词
Copeptin; Arginine vasopressin; Biomarker; Prognostic markers; TERMINAL PROVASOPRESSIN COPEPTIN; ACUTE MYOCARDIAL-INFARCTION; TRANSIENT ISCHEMIC ATTACK; VASOPRESSIN PRECURSOR; ARGININE-VASOPRESSIN; DIABETES-INSIPIDUS; PLASMA COPEPTIN; STABLE PEPTIDE; SERUM COPEPTIN; HEART-FAILURE;
D O I
10.1016/j.ab.2023.115181
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Arginine Vasopressin (AVP) is one of the key hormones in the human body. AVP is clinically important because it maintains body fluid balance and vascular tone. Unfortunately, AVP laboratory measurements are always difficult and with low accuracy. Copeptin, the C-terminal of the AVP precursor, is released in equal amounts with AVP, making it a sensitive marker of AVP release. Despite being a non-specific biomarker, copeptin earned a lot of attention as a novel biomarker due to easy and quick laboratory measurements. Recent studies have reported the critical role of copeptin as a clinical indicator, especially in the diagnosis and prognosis of many diseases. Besides, it was reported that the combination between copeptin and gold standard biomarkers improved the prognostic values of those biomarkers. In this review, the role of copeptin as a new predictive diagnostic and prognostic biomarker of various diseases is highlighted according to the most recent studies. In addition, the importance of using copeptin as a marker in different medical departments and the impact of this on improving healthcare service was discussed.
引用
收藏
页数:16
相关论文
共 141 条
[1]   Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study [J].
Agorastos, Agorastos ;
Sommer, Anne ;
Heinig, Alexandra ;
Wiedemann, Klaus ;
Demiralay, Cueneyt .
FRONTIERS IN PSYCHIATRY, 2020, 11
[2]   Association of Copeptin and N-Terminal proBNP Concentrations With Risk of Cardiovascular Death in Older Patients With Symptoms of Heart Failure [J].
Alehagen, Urban ;
Dahlstroem, Ulf ;
Rehfeld, Jens F. ;
Goetze, Jens P. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (20) :2088-2095
[3]  
[Anonymous], Top 10 Causes of Death
[4]  
[Anonymous], PER ASPH
[5]  
[Anonymous], DRAFT INT GLOB ACT P
[6]  
[Anonymous], 2021, Mental health
[7]   Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus [J].
Arima, Hiroshi ;
Cheetham, Timothy ;
Christ-Crain, Mirjam ;
Cooper, Deborah L. ;
Drummond, Juliana B. ;
Gurnell, Mark ;
Levy, Miles ;
McCormack, Ann ;
Newell-Price, John D. ;
Verbalis, Joseph G. ;
Wass, John .
ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (06) :868-870
[8]   Burden of liver diseases in the world [J].
Asrani, Sumeet K. ;
Devarbhavi, Harshad ;
Eaton, John ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2019, 70 (01) :151-171
[9]   Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study [J].
Atila, Cihan ;
Gaisl, Odile ;
Vogt, Deborah R. ;
Werlen, Laura ;
Szinnai, Gabor ;
Christ-Crain, Mirjam .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2022, 187 (01) :65-74
[10]   Correlation of Plasma Copeptin and Vasopressin Concentrations in Hypo-, Iso-, and Hyperosmolar States [J].
Balanescu, Sandrina ;
Kopp, Peter ;
Gaskill, Mary Beth ;
Morgenthaler, Nils G. ;
Schindler, Christian ;
Rutishauser, Jonas .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04) :1046-1052